GSK-2018682 free base · Synonyms: GSK 2018682 · GSK2018682
GSK2018682 is an agonist for S1P1 and S1P5 receptor with pEC50s of 7.7 and 7.2, respectively, and has no agonist activity towards human S1P2, S1P3…
For research use only. Not for human or veterinary use.
Target
LPL Receptor
Research area
Inflammation/Immunology
Purity >98%
Stock Inquire
GSK-2018682 structure
CAS No.: 1034688-30-6
Pack sizes & pricing
Description
GSK2018682 is an agonist for S1P1 and S1P5 receptor with pEC50s of 7.7 and 7.2, respectively, and has no agonist activity towards human S1P2, S1P3, or S1P4. GSK2018682 is used in the research of multiple sclerosis.
Biological activity
In Vitro GSK2018682 is an agonist for S1P1 and S1P5 receptor with pEC50s of 7.7 and 7.2, respectively, and has no agonist activity towards human S1P2, S1P3, or S1P4.
Identifiers
- SMILES
-
CC(C)OC1=C(Cl)C=C(C=N1)C1=NC(=NO1)C1=C2C=CN(CCCC(O)=O)C2=CC=C1 - InChIKey
-
NFIGDBFIDKDNIG-UHFFFAOYSA-N
Specifications
- MW (average)
- 440.8800
- Formula
- C22H21ClN4O4
- CAS No.
- 1034688-30-6
- Physical state
- Solid
- Color
- White to off-white
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder 40℃ 2 years; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO
Documents
References
[1]. Xu J, et al. Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteers. Clin Pharmacol Drug Dev. 2014 May;3(3):170-8.